Bioactivity | VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1]. | ||||||||||||
Invitro | VHL Ligand 14 (5-10 μM) 维持 PROTAC 中 ER 降解剂的稳定性,促进 ER 降解[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> VHL Ligand 14 相关抗体: Western Blot Analysis[1] Cell Line: | ||||||||||||
CAS | 2010986-87-3 | ||||||||||||
Formula | C25H34N4O4S | ||||||||||||
Molar Mass | 486.63 | ||||||||||||
Appearance | 固体 | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Hu J, et al., Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER). J Med Chem. 2019 Feb 14;62(3):1420-1442. |